Isolation of a tumor neoantigen specific CD8+ TCR from a skin biopsy of a vaccination site
T cells that recognize tumor-specific mutations are crucial for cancer immunosurveillance and in adoptive transfer of TILs or transgenic-TCR T cell products. However, their challenging identification and isolation limits their use in clinical practice. Therefore, novel approaches to isolate tumor-sp...
Saved in:
Main Authors: | Maria Paula Roberti, Pornpimol Charoentong, Yanhong Lyu, Marten Meyer, Stefan B. Eichmüller, Patrick Schmidt, Frank Momburg, Miray Cetin, Felix Hartmann, Nektarios A. Valous, Albrecht Stenzinger, Laura Michel, Peter Lichter, Andreas Schneeweiss, Verena Thewes, Carlo Fremd, Inka Zörnig, Dirk Jäger |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2025-12-01
|
Series: | OncoImmunology |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/2162402X.2025.2457793 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Ddx21 mutant peptide is an effective neoantigen in prophylactic lung cancer vaccines and activates long-term anti-tumor immunity
by: Zhe Zhang, et al.
Published: (2025-02-01) -
Unveiling immunogenic characteristics and neoantigens in endometrial cancer with POLE hotspot mutations for improved immunotherapy
by: Jian Huang, et al.
Published: (2025-01-01) -
Advances in nucleic acid-based cancer vaccines
by: Hung-Chun Liao, et al.
Published: (2025-01-01) -
Editorial: Antigen presentation in cancer immune responses
by: Marie-Liesse Asselin-Labat, et al.
Published: (2025-01-01) -
Neoantigen immunotherapy: a novel treatment for bladder cancer
by: Ruiyang Lv, et al.
Published: (2025-01-01)